{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T06:49:12Z","timestamp":1791614952277,"version":"4.3.4"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,4,13]],"date-time":"2013-04-13T00:00:00Z","timestamp":1365811200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Exp Nephrol"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1007\/s10157-013-0806-8","type":"journal-article","created":{"date-parts":[[2013,4,12]],"date-time":"2013-04-12T07:01:50Z","timestamp":1365750110000},"page":"50-55","source":"Crossref","is-referenced-by-count":100,"title":["Uric acid transporter ABCG2 is increased in the intestine of the 5\/6 nephrectomy rat model of chronic kidney disease"],"prefix":"10.1007","volume":"18","author":[{"given":"Hirofumi","family":"Yano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshifuru","family":"Tamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kana","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Tanemoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunya","family":"Uchida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,4,13]]},"reference":[{"key":"806_CR1","unstructured":"K\/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39:S1\u2013266."},{"key":"806_CR2","doi-asserted-by":"crossref","first-page":"706","DOI":"10.2215\/CJN.04271007","volume":"3","author":"ET Rosolowsky","year":"2008","unstructured":"Rosolowsky ET, Ficociello LH, Maselli NJ, et al. High-normal serum uric acid is associated with impaired glomerular filtration rate in nonproteinuric patients with type 1 diabetes. Clin J Am Soc Nephrol. 2008;3:706\u201313.","journal-title":"Clin J Am Soc Nephrol"},{"key":"806_CR3","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.2337\/dc10-0227","volume":"33","author":"LH Ficociello","year":"2010","unstructured":"Ficociello LH, Rosolowsky ET, Niewczas MA, et al. High-normal serum uric acid increases risk of early progressive renal function loss in type 1 diabetes: results of a 6-year follow-up. Diabetes Care. 2010;33:1337\u201343.","journal-title":"Diabetes Care"},{"key":"806_CR4","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1161\/HYPERTENSIONAHA.111.171488","volume":"58","author":"Y Miao","year":"2011","unstructured":"Miao Y, Ottenbros SA, Laverman GD, et al. Effect of a reduction in uric acid on renal outcomes during losartan treatment: a post hoc analysis of the reduction of endpoints in non-insulin-dependent diabetes mellitus with the Angiotensin II Antagonist Losartan Trial. Hypertension. 2011;58:2\u20137.","journal-title":"Hypertension"},{"key":"806_CR5","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1681\/ASN.V641313","volume":"6","author":"ND Vaziri","year":"1995","unstructured":"Vaziri ND, Freel RW, Hatch M. Effect of chronic experimental renal insufficiency on urate metabolism. J Am Soc Nephrol. 1995;6:1313\u20137.","journal-title":"J Am Soc Nephrol"},{"key":"806_CR6","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/nature742","volume":"417","author":"A Enomoto","year":"2002","unstructured":"Enomoto A, Kimura H, Chairoungdua A, et al. Molecular identification of a renal urate anion exchanger that regulates blood urate levels. Nature. 2002;417:447\u201352.","journal-title":"Nature"},{"key":"806_CR7","doi-asserted-by":"crossref","first-page":"e194","DOI":"10.1371\/journal.pgen.0030194","volume":"3","author":"S Li","year":"2007","unstructured":"Li S, Sanna S, Maschio A, et al. The GLUT9 gene is associated with serum uric acid levels in Sardinia and Chianti cohorts. PLoS Genet. 2007;3:e194.","journal-title":"PLoS Genet"},{"key":"806_CR8","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/ng.107","volume":"40","author":"A Doring","year":"2008","unstructured":"Doring A, Gieger C, Mehta D, et al. SLC2A9 influences uric acid concentrations with pronounced sex-specific effects. Nat Genet. 2008;40:430\u20136.","journal-title":"Nat Genet"},{"key":"806_CR9","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/ng.106","volume":"40","author":"V Vitart","year":"2008","unstructured":"Vitart V, Rudan I, Hayward C, et al. SLC2A9 is a newly identified urate transporter influencing serum urate concentration, urate excretion and gout. Nat Genet. 2008;40:437\u201342.","journal-title":"Nat Genet"},{"key":"806_CR10","doi-asserted-by":"crossref","first-page":"26834","DOI":"10.1074\/jbc.C800156200","volume":"283","author":"N Anzai","year":"2008","unstructured":"Anzai N, Ichida K, Jutabha P, et al. Plasma urate level is directly regulated by a voltage-driven urate efflux transporter URATv1 (SLC2A9) in humans. J Biol Chem. 2008;283:26834\u20138.","journal-title":"J Biol Chem"},{"key":"806_CR11","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.ajhg.2008.11.001","volume":"83","author":"H Matsuo","year":"2008","unstructured":"Matsuo H, Chiba T, Nagamori S, et al. Mutations in glucose transporter 9 gene SLC2A9 cause renal hypouricemia. Am J Hum Genet. 2008;83:744\u201351.","journal-title":"Am J Hum Genet"},{"key":"806_CR12","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1016\/S0140-6736(08)61343-4","volume":"372","author":"A Dehghan","year":"2008","unstructured":"Dehghan A, Kottgen A, Yang Q, et al. Association of three genetic loci with uric acid concentration and risk of gout: a genome-wide association study. Lancet. 2008;372:1953\u201361.","journal-title":"Lancet"},{"key":"806_CR13","doi-asserted-by":"crossref","first-page":"e1000504","DOI":"10.1371\/journal.pgen.1000504","volume":"5","author":"M Kolz","year":"2009","unstructured":"Kolz M, Johnson T, Sanna S, et al. Meta-analysis of 28,141 individuals identifies common variants within five new loci that influence uric acid concentrations. PLoS Genet. 2009;5:e1000504.","journal-title":"PLoS Genet"},{"key":"806_CR14","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/ng.531","volume":"42","author":"Y Kamatani","year":"2010","unstructured":"Kamatani Y, Matsuda K, Okada Y, et al. Genome-wide association study of hematological and biochemical traits in a Japanese population. Nat Genet. 2010;42:210\u20135.","journal-title":"Nat Genet"},{"key":"806_CR15","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/sj.ki.5002645","volume":"73","author":"M Huls","year":"2008","unstructured":"Huls M, Brown CD, Windass AS, et al. The breast cancer resistance protein transporter ABCG2 is expressed in the human kidney proximal tubule apical membrane. Kidney Int. 2008;73:220\u20135.","journal-title":"Kidney Int"},{"key":"806_CR16","first-page":"3458","volume":"61","author":"M Maliepaard","year":"2001","unstructured":"Maliepaard M, Scheffer GL, Faneyte IF, et al. Subcellular localization and distribution of the breast cancer resistance protein transporter in normal human tissues. Cancer Res. 2001;61:3458\u201364.","journal-title":"Cancer Res"},{"key":"806_CR17","doi-asserted-by":"crossref","first-page":"7340","DOI":"10.1038\/sj.onc.1206938","volume":"22","author":"L Doyle","year":"2003","unstructured":"Doyle L, Ross DD. Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2). Oncogene. 2003;22:7340\u201358.","journal-title":"Oncogene"},{"key":"806_CR18","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/ncomms1756","volume":"3","author":"K Ichida","year":"2012","unstructured":"Ichida K, Matsuo H, Takada T, et al. Decreased extrarenal urate excretion is a common cause of hyperuricemia. Nat Commun. 2012;3:764.","journal-title":"Nat Commun"},{"key":"806_CR19","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.0954-6820.1977.tb16776.x","volume":"202","author":"S Madsen","year":"1977","unstructured":"Madsen S, Olgaard K, Thaysen JH. The effect of 1-alpha-hydroxycholecalciferol on the renal handling of phosphate in parathyroidectomized man. Acta Med Scand. 1977;202:23\u20136.","journal-title":"Acta Med Scand"},{"key":"806_CR20","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1172\/JCI111448","volume":"74","author":"M Yamamoto","year":"1984","unstructured":"Yamamoto M, Kawanobe Y, Takahashi H, et al. Vitamin D deficiency and renal calcium transport in the rat. J Clin Invest. 1984;74:507\u201313.","journal-title":"J Clin Invest"},{"key":"806_CR21","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1056\/NEJMra0800885","volume":"359","author":"DI Feig","year":"2008","unstructured":"Feig DI, Kang DH, Johnson RJ. Uric acid and cardiovascular risk. N Engl J Med. 2008;359:1811\u201321.","journal-title":"N Engl J Med"},{"key":"806_CR22","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/BOR.0b013e3283257b96","volume":"21","author":"NL Edwards","year":"2009","unstructured":"Edwards NL. The role of hyperuricemia in vascular disorders. Curr Opin Rheumatol. 2009;21:132\u20137.","journal-title":"Curr Opin Rheumatol"},{"key":"806_CR23","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1056\/NEJM197906283002604","volume":"300","author":"GR Boss","year":"1979","unstructured":"Boss GR, Seegmiller JE. Hyperuricemia and gout. Classification, complications and management. N Engl J Med. 1979;300:1459\u201368.","journal-title":"N Engl J Med"},{"key":"806_CR24","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1002\/art.1780080429","volume":"8","author":"LB Sorensen","year":"1965","unstructured":"Sorensen LB. Role of the intestinal tract in the elimination of uric acid. Arthritis Rheum. 1965;8:694\u2013706.","journal-title":"Arthritis Rheum"},{"key":"806_CR25","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1159\/000180432","volume":"14","author":"LB Sorensen","year":"1975","unstructured":"Sorensen LB, Levinson DJ. Origin and extrarenal elimination of uric acid in man. Nephron. 1975;14:7\u201320.","journal-title":"Nephron"},{"key":"806_CR26","doi-asserted-by":"crossref","first-page":"10338","DOI":"10.1073\/pnas.0901249106","volume":"106","author":"OM Woodward","year":"2009","unstructured":"Woodward OM, Kottgen A, Coresh J, et al. Identification of a urate transporter, ABCG2, with a common functional polymorphism causing gout. Proc Natl Acad Sci USA. 2009;106:10338\u201342.","journal-title":"Proc Natl Acad Sci USA"},{"key":"806_CR27","doi-asserted-by":"crossref","first-page":"5ra11","DOI":"10.1126\/scitranslmed.3000237","volume":"1","author":"H Matsuo","year":"2009","unstructured":"Matsuo H, Takada T, Ichida K, et al. Common defects of ABCG2, a high-capacity urate exporter, cause gout: a function-based genetic analysis in a Japanese population. Sci Transl Med. 2009;1:5ra11.","journal-title":"Sci Transl Med"}],"container-title":["Clinical and Experimental Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-013-0806-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10157-013-0806-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-013-0806-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,13]],"date-time":"2022-02-13T16:46:33Z","timestamp":1644770793000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10157-013-0806-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4,13]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["806"],"URL":"https:\/\/doi.org\/10.1007\/s10157-013-0806-8","relation":{},"ISSN":["1342-1751","1437-7799"],"issn-type":[{"value":"1342-1751","type":"print"},{"value":"1437-7799","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,13]]}}}